Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Association of Chemotherapy Timing in Pregnancy With Congenital Malformation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Assessment of Seasonality and Extremely Preterm Birth in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Adverse Pregnancy Outcomes and Incident Heart Failure in the Women's Health Initiative

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Questionnaires vs Interviews for the Assessment of Global Functional Outcomes After Traumatic Brain Injury

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Survival in Women Diagnosed With Breast Cancer During Pregnancy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cancer in pregnancy increases the risk of venous thromboembolism: A nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Biologiske antireumatika til gravide og ammende kvinder eller mandlige partnere

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Præterm fødsel

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologipeer review

  • International Network on Cancer, Infertility and Pregnancy
  • Lone Storgaard (Medlem af forfattergruppering)
Vis graf over relationer

Importance: Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.

Objective: To assess congenital malformation rates associated with gestational age at initiation of chemotherapy among pregnant women with cancer.

Design, Setting, and Participants: This multicenter cohort study evaluated all pregnant women who received chemotherapy between 1977 and 2019 registered in the International Network on Cancer, Infertility and Pregnancy (INCIP) database. Data were analyzed from February 15 to June 2, 2020.

Exposures: Cancer treatment with chemotherapy during pregnancy.

Main Outcomes and Measures: Analysis was focused on major and minor structural malformations in offspring, defined by EUROCAT, detected during pregnancy or at birth.

Results: A total of 755 women in the INCIP database who underwent cancer treatment with chemotherapy during pregnancy were included in analysis. The median (range) age at cancer diagnosis was 33 (14-48) years. Among offspring, the major congenital malformation rate was 3.6% (95% CI, 2.4%-5.2%), and the minor congenital malformation rate was 1.9% (95% CI, 1.0%-3.1%). Chemotherapy exposure prior to 12 weeks gestational age was associated with a high rate of major congenital malformations, at 21.7% (95% CI, 7.5%-43.7%; odds ratio, 9.24 [95% CI, 3.13-27.30]). When chemotherapy was initiated after gestational age 12 weeks, the frequency of major congenital malformations was 3.0% (95% CI, 1.9%-4.6%), which was similar to the expected rates in the general population. Minor malformations were comparable when exposure occurred before or after gestational age 12 weeks (4.3% [95% CI, 0.1%-21.9%] vs 1.8% [95% CI, 1.0-3.0]; odds ratio, 3.13 [95% CI, 0.39-25.28]). Of 29 women who received chemotherapy prior to 12 weeks gestation, 17 (58.6%) were not aware of pregnancy, and 6 (20.7%) experienced a miscarriage (3 women [10.3%]) or decided to terminate their pregnancy (3 women [10.3%]).

Conclusions and Relevance: This cohort study found that chemotherapy was associated with an increased risk of major congenital malformations only in the first 12 weeks of pregnancy. The risk of congenital malformations when chemotherapy was administered during the first trimester and the high number of incidental pregnancies during cancer treatment in the INCIP registry underscore the importance of contraceptive advice and pregnancy testing at the start of chemotherapeutic treatment in young women with cancer.

OriginalsprogEngelsk
Artikelnummere202113180
TidsskriftJAMA network open
Vol/bind4
Udgave nummer6
Sider (fra-til)e2113180
ISSN2574-3805
DOI
StatusUdgivet - 1 jun. 2021

ID: 70645937